Bristol-Myers Squibb Company annual earnings per share (EPS) for fiscal TTM was $3.57, an increase of 3.2% from $3.46 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $3.57 | $3.46 | $-4.41 | $3.86 | $2.95 | $3.12 | $-3.98 | $2.01 | $3.01 | $0.61 | $2.65 | $0.93 | $1.20 | $1.54 | $1.16 | $2.16 | $1.80 | $5.37 | $2.62 | $1.09 | $0.81 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $1.31 | $0.53 | $1.08 | $0.64 | $1.21 | $0.04 | $0.60 | $0.83 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More BMY metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All BMY financial statements → Interactive BMY charts →
About TickerBase · Data methodology & sources